JVs’ performance beats; Trumpchi under pressure; balance sheet solid
Profit may continue to beat in next few quarters
3Q rev/np +3%/59%; cost cut was key to profit growth
Peptide business becoming a new growth driver
Huayu and financial business drive 1Q profit; JVs profitability weakens